Biography

Dr. Fox joined IDRI in 2007 as a formulation scientist and has played an integral role in developing, characterizing, and manufacturing cGMP vaccine adjuvant formulations for a variety of infectious diseases, including leishmaniasis, malaria, tuberculosis, and pandemic influenza. Dr. Fox has authored or coauthored over 40 publications on the development or characterization of formulations for adjuvants or drugs, including emulsions, liposomes, nanosuspensions, and aluminum salts. He is principal investigator on a cooperative agreement from the Biomedical Advanced Research and Development Authority of the US government to transfer emulsion adjuvant manufacturing technology to the Cantacuzino Institute in Bucharest, Romania to facilitate pandemic influenza vaccine production. He has also participated in technology transfer projects in Brazil and India, in addition to serving as a faculty member for the Advanced Vaccinology Course in India (2010-2014) funded in part by the Gates Foundation, and for the online Latin American Diploma on Vaccinology sponsored by the Carlos Slim Health Institute. Dr. Fox obtained his Ph.D. in Bioengineering at the University of Utah and his B.S. in Biological Engineering at Utah State University.